Article Navigation Heading

An Observational Study of a Time-Restricted Eating Regimen on a Cohort of Participants at an Intermittent Fasting Clinic.


Priya Chaudhary1, Rajesh Hydrabadi2, Sumit Prajapati2and Divya Chandel1*

1Department of Zoology, Biomedical Technology, and Human Genetics, Gujarat University, Ahmedabad, India

2Cardiovascular Clinic, Satellite, Ahmedabad, India

Corresponding Author E-mail:divyachandel@gujaratuniversity.ac.in

Download this article as: 

ABSTRACT:

Overweight and obesity prevalence present significant health challenges on a global scale. Hence, the objective was to explore the effects of atime restricted eating(TRE) protocol on a specific group of participants for weight-loss management.This was an observational study with participants recruited from a specialized clinic, the Intermittent Fasting Research Foundation, Ahmedabad, Gujarat, over a period of 6-months. Obesity was evaluated using the BMI and all Anthropometric parameters were quantified using the bioelectrical impedance method. First month was completed by 239 participants, followed by 224 in the second month, 89 in the third month, 39,19 and 8 for the fourth, fifth and sixth month respectively.A severe attrition rate was observeddue to either having achieved goals or difficulty in following protocol.Each patient was provided a personalized diet and TREunder medical supervision, tailored to their specific needs and weight loss objectives.We consistently observed a statistically significant overall decrease in body weight, BMI, visceral fat, subcutaneous fat, and waist circumference atone-month interval throughout the six-month study period. Furthermore, the absence of skeletal muscle mass loss suggests that the decrease in BMI was not due to muscle loss.These observations suggest that TRE may be a safe and effective intervention for overweight and obese individuals who are highly motivated.

KEYWORDS:

BMI; Body composition; Obesity; Resting metabolic rate; Skeletal muscle mass; Visceral fat; Weight loss

Introduction

The progress of technology coupled with the easy availability of food and decreased physical activity has created a modern-day curse on the human race, referred to as “Lifestyle disorders”.Obesity is undeniably one of the most prevalent chronic diseases that pose a serious challenge to global healthwith its comorbidities and the ensuing death overtime.1According to the World Health Organization (WHO),about 13% of the world’s adult population (15% of women and 11% of men) were obese in 2016. Occurrence of obesity nearly tripled between 1975 and 2016.2The etiology of obesity is widely regarded as multifactorial, with a complex interplay between obesity-associated genes and several environmental factors. Obesity and overweight condition are significant health concern that, independently and in association with other diseases, causes or exacerbates many health issues. These health issues include but are not limited to insulin resistance, type 2 diabetes, heart disease, hypertension, osteoarthritis, respiratory complications, and an increased incidence of certain forms of cancer.Maintaining a healthy weight is paramount to reducing the risk of developing these conditions. Even a slight reduction of 1 kg in body weight can have a significant impact on reducing the risk of developing diabetes by as much as 16%.3 The repercussions of obesity on health can be severe; hence, it is crucial to take necessary steps to manage weight.Consequently, those seeking a simple fix are turning to various diet plans.Nowadays, many researchers have been exploring intermittent fasting (IF) as a potential substitutefor traditional continuous energy restriction (ER) methods for weight loss. IF has gained considerable attention and interest in the scientific community as a viable approach to weight management.4It is essential to understand that therapeutic fasting is a controlled and voluntary action of abstaining from calorie-containing foods and drinks for a specific time; this is entirely different from the involuntary and uncontrolled act of starvation.5 Fasting is a powerful eating pattern that revolves around the idea of restricting calorie intake for extended periods. This pattern helps to give the body a break from constant digestion and allows it to use stored energy for fuel.It is an effective, costless, natural dietary intervention promoting health and preventing ageing and diseases.1 The term “intermittent fasting” has been employed to describe various types of caloric restriction for the purpose of health and weight loss. Alternate-day fasting involves fasting one day followed by unrestricted eating on the next. Periodic regimen is another method where individual fasts for one or two days a week, also referred to as 5:2 or 6:1 fasting. Time-restricted eating is a widely adopted method for regulating food consumption. This approach involves limiting the time window for meals, typically with a daily fast of 16-20 hours and 8-4 hours feeding period.6 Here, we aimed to study the impact of time restricted eating (TRE) on overweight and obese individuals.

Materials and Methods

This research has been approved by the Institutional Human Ethical Committee of Gujarat University (Ref: GU-IEC(Niv)/02/PhD/033) and written informed consent was obtained from all subjects. An observational cohort study was conducted at the Intermittent Fasting Research Foundation (IFRF), Ahmedabad. The IFRF works with clients to adopt and use time restricted eating for metabolic syndromes. The clinic data is being used to understand the effects of TRE on weight loss.Two hundred and thirty-nine individuals completed the first month of the study, and 224 individuals completed the second month. Moving forward, 89 patients were able to complete the third month of the study, while only 39 and 19 individuals completed the fourth and fifth months, respectively. Finally, only eight patients continued the study through the sixth month. The number of participants decreased significantly in the following months owing either to a challenge in continuing, orhaving achieved their goals.

Inclusion Criteria consisted ofindividualsaged >18 years, who had BMI above 20and wanted to lose weight due to health purposes and fitness goals, andobese or overweight women and men with a BMI above 25.Exclusion Criteria consisted of people on chronic medication or pregnant and lactating women.Obesity was evaluated using the BMI, and all Anthropometric parameters were quantified using the bioelectrical impedance method by Karada scan.Theparameters such as height, weight, and waist circumference were recorded.Karada scan data, including body fat, visceral fat, subcutaneous fat, resting metabolism, BMI, and skeletal muscle mass,were measured at fifteen days interval.

Dietary interventions: The patients in the study were firmly instructed to follow a specific eating and fasting scheduleand were instructed to fast for 16-14 hours and consume their meals within an 8-10 hour feeding window daily throughout the study period. There were no specific uniform dietary intake requirements; each patient received a customised diet and fasting plan under medical supervision and weight loss goals following a thorough examination. This flexible dietary plan is a great advantage because it allows individuals to design meal plans according to their food preferences. Also, nutritional and balanced food education was given to each individual at the start.

The patients adhered to a dietary regimen whichemphasized consuming  whole foods and unprocessed unsaturated fats.  Furthermore, they significantly reduced their intake of sugars and refined carbohydrates while concurrently increasing their consumption of natural fats. Without strictly counting calories, all reported satiety. During fasting, they were permitted zero-calorie fluids, including water, green tea, black tea and black coffee.The fasting window and diet were self-monitored by the patients themselvesand we have not focused on tracking of other variables such as physical activity.

Statistical methods: Statistical analyses were performed using GraphPad prism version 8.0.1. Data are presented as mean ± SD.Data within experiments were evaluated by repeated measures one-way ANOVA with Geisser-Greenhouse correction testing where appropriate. All tests were two-tailed and conducted at a 95% confidence interval. The mean effect sizewas calculated using Cohen’s d metric. Statistical significance was accepted at p<0.05.

Results

All the individuals were classified into three groups according to their BMI: Group 1 (Normal), Group 2 (Overweight) and Group 3 (Obese).

Table 1: Shows Anthropometric data before and after 1 month of Intermittent Fasting

Parameters

Before IF After 1st month(n=239)

Percent Change

BMI

32.01±5.33 30.69±4.98**** 4.12%↓
Group 1 23.87±0.70

23.24 ±0.58**

Group 2

27.61±1.27 26.56±1.31****
Group 3 35.48±4.34

33.93±4.05****

BODY WEIGHT

85.64±17.48 82.36±16.84* 3.82%↓
Group 1 66.12±6.34

64.33±5.19**

Group 2

72.99±9.11 70.22±9.12****
Group 3 95.35±15.68

91.69±15.10 NS

BODY FAT

37.77±5.34 36.89±5.45**** 2.32%↓
Group 1 28.16±3.83

26.76±3.63*

Group 2

35.80±4.68 34.97±4.67****
Group 3 39.63±4.65

38.76±4.82****

VISCERAL FAT

17.23±17.19 15.86±7.13**** 7.95%↓
Group 1 8.33±3.07

7.44±2.80 NS

Group 2

11.67±3.57 10.53±3.58****
Group 3 21.51±6.02

19.96±6.22****

RESTING METABOLISM

1650.61±333.09 1611.14±386.29* 2.39%↓
Group 1 1449.55±174.50

1424.55±153.94 NS

Group 2

1476.07±214.56 1389.72±308.81**
Group 3 1786.09±341.5

1770.92±365.48 NS

SUBCUTANEOUS FAT

32.42±7.51 31.02±7.41**** 4.31%↓
Group 1 24.00±5.22

21.84±4.70*

Group 2

30.26±5.86 28.85±5.59****
Group 3 34.40±7.87

33.06±7.77****

SKELETAL MUSCLE MASS

23.76±3.51 24.13±3.54**** 1.5%↑
Group 1 27.81±4.07

28.62±4.11*

Group 2

24.02±3.45 24.51±3.24*
Group 3 23.32±3.33

23.59±3.45*

WAIST CIRCUMFERENCE

107.60±13.57 101.71±14.29**** 5.47%↓
Group 1 93.28±9.58

88.35±9.13**

Group 2

98.46±7.98 93.68±6.90****
Group 3 114±12.66

107.37±15.03****

Data are represented as mean ± SD ****p<0.0001 ***p<0.001 **p<0.01 ns = non-significant

Group 1: Normal BMI, Group 2: Overweight, Group 3: Obesity

Table 1 shows the data of 239 individuals who completed their first month of fasting,where the first group comprised 9 participants with a normal BMI, while the second group included 92 participants andthe third group, consisted of 138 individuals.During the first month of fasting, there was a decrease of 4.12% and 3.82% in BMI and weight, respectively in all the cases. However, there was a non-significant reduction in the body weight of the obese group.Moreover, body fat decreased by 2.32%, and visceral fat decreased by 7.95%. The mean visceral fat in the normal BMI group did not significantly decrease from 8.33 to 7.44. The resting metabolism decreased by 2.39%, and there was a non-significant change in groups 1 and 3. The skeletal muscle mass significantly increased by 1.5%. Additionally, waist circumference and subcutaneous fat were reduced by 5.47% and 4.31%, respectively.

Table 2: Shows Anthropometric data before and after 2 months of Intermittent Fasting

Parameters

Before IF After 2nd month(n=224)

Percent Change

BMI

32.33±5.42 30.47±4.95**** 4.12%↓
Group 1 23.87±0.70

22.9±0.43***

Group 2

27.62±1.29 26.22±1.41****
Group 3 35.57±4.38

33.38±4.04****

BODY WEIGHT

86.91±17.80 81.78±17.31**** 3.82%↓
Group 1 66.12±6.34

63.17±5.88***

Group 2

73.45±9.13 69.69±9.13****
Group 3 95.94±15.98

89.89±16.40****

BODY FAT

37.85±5.37 36.24±5.70**** 4.25%↓
Group 1 28.16±3.83

25.66±3.51**

Group 2

35.75±4.58 34.08±4.72****
Group 3 39.59±4.73

38.07±5.08****

VISCERAL FAT

17.55±7.32 15.55±7.14**** 11.39%↓
Group 1 8.33±3.07

7.44±2.79*

Group 2

11.63±3.74 10.75±3.70****
Group 3 21.52±6.16

19.24±6.31****

RESTING METABOLISM

1670.40±339.07 1611.87±322.16** 3.5%↓
Group 1 1449.55±174.50

1408.44±153.60 NS

Group 2

1472.79±216.49 1426.03±204.18*
Group 3 1797.42±343.96

1731.06±329.13*

SUBCUTANEOUS FAT

32.55±7.54 30.36±7.57**** 6.72%↓
Group 1 24.00±5.22

21.33±4.67*

Group 2

30.33±5.79 28.04±5.77****
Group 3 34.37±7.85

32.29±7.83****

SKELETAL MUSCLE MASS

23.82±3.52 24.63±3.80**** 3.40%↑
Group 1 27.81±4.07

29.05±4.21*

Group 2

24.08±3.46 25.09±3.64***
Group 3 23.41±3.35

24.09±3.65****

WAIST CIRCUMFERENCE

108.38±13.82 101.37±12.73**** 6.46%↓
Group 1 93.28±9.58

86.57±9.07**

Group 2

98.75±8.85 92.90±7.05****
Group 3 114.22±12.67

106.60±12.17****

Data are represented as mean ± SD ****p<0.0001 ***p<0.001 **p<0.01 ns = non-significant

Group 1: Normal BMI, Group 2: Overweight, Group 3: Obesity

Table 2 reveals that 224 people finished their two-month fasting protocol. Group 1 had 9 participants, while Group 2 and Group 3 had 78 and 137 individuals. BMI wasreduced by 4.12%, weight by 3.82%,body fat by 4.25%, visceral fat by 11.39%;while theskeletal muscle mass increased by 3.40%. Their resting metabolism decreased by 3.5%, and was non-significant for Group 1. Waist circumference and subcutaneous fat were reducedby 6.46% and 6.72% respectively.

Table 3: Shows Anthropometric data before and after 3 months of Intermittent Fasting

Parameters parameter

Before IF After 3rd month(n=89)

Percent Change

BMI

32.51±5.05 30.08±4.40**** 7.47%↓
Group 1 23.72±0.73

21.9±0.61 NS

Group 2

27.78±1.32 25.93±1.17****
Group 3 35.065±4.00

32.36±3.34****

BODY WEIGHT

85.29±17.69 81.88±16.38**** 3.99%↓
Group 1 65.15±7.42

61.05±6.21*

Group 2

73.75±8.54 68.83±8.13****
Group 3 95.95±16.66

88.70±14.92****

BODY FAT

38.02±5.46 35.87±5.90**** 5.65%↓
Group 1 30.72±0.78

27.1±3.37NS

Group 2

35.46±5.46 33.57±5.87****
Group 3 39.57±4.85

37.41±5.23****

VISCERAL FAT

18.19±6.59 15.38±6.18**** 15.55%↓
Group 1 8.62±3.90

6.65±2.05 NS

Group 2

11.84±2.71 9.78±2.27****
Group 3 21.48±5.18

18.30±5.24****

RESTING METABOLISM

1697.56±370.53 1634.03±304.96 NS 3.74%↓
Group 1 1415.25±189.52

1363.5±166.51*

Group 2

1493.08±201.04 1427.96±192.35 NS
Group 3 1801.58±390.36

1737.93±297.18 NS

SUBCUTANEOUS FAT

32.28±7.65 30±7.61**** 7.06%↓
Group 1 23.67±3.61

20.45±6.00NS

Group 2

30.10±6.35 28.03±6.30****
Group 3 33.77±7.80

31.45±7.65****

SKELETAL MUSCLE MASS

23.70±3.39 24.72±3.77**** 4.30%↑
Group 1 26.57±2.12

27.82±2.47 NS

Group 2

24.37±3.32 25.53±3.84 NS
Group 3 23.32±3.40

24.28±3.73****

WAIST CIRCUMFERENCE

109.94±13.40 100.5±12.39**** 8.58%↓
Group 1 95.25±12.14

83.75±12.41**

Group 2

100.22±7.57 92.20±7.16****
Group 3 114.98±12.50

105.08±11.41****

Data are represented as mean ± SD ****p<0.0001 ***p<0.001 **p<0.01 ns = non-significant

Group 1: Normal BMI, Group 2: Overweight, Group 3: Obesity

Table 3 shows that 89 participants finished three months of fasting. Only four individuals remained in Group 1, and groups 2 and 3 had 25 and 60 subjects respectively. The BMI, body fat, visceral fat, and subcutaneous fat were reduced by 7.47%, 5.65%, 15.55%, and 7.06% respectively. All these four parameters of normal BMI individuals were non-significant. Body weight and waist circumference significantly reduced in 3rd month by 3.99% and 8.58%. Resting metabolism decreased non-significantly by 3.74 %, and skeletal muscle mass improved considerably by 4.30%.

Table 4: Shows Anthropometric data before and after 4 months of Intermittent Fasting

Parameters

Before IF After 4th month(n=39)

Percent Change

BMI

33.74±5.11 30.36±4.16**** 10.01%↓
Group 1 0

0

Group 2

28.03±1.45 25.67±1.16****
Group 3 35.45±4.53

31.77±0.66****

BODY WEIGHT

91.26±19.25 82.30±16.36**** 9.81%↓
Group 1 0

0

Group 2

71±5.79 65.04±5.08****
Group 3 97.34±17.63

87.48±14.95****

BODY FAT

39.05±4.67 36.11±5.46**** 7.52%↓
Group 1 0

0

Group 2

35.82±5.62 33.31±7.18**
Group 3 40.02±3.96

36.96±4.66****

VISCERAL FAT

19.76±6.35 15.79±6.16**** 20.09%↓
Group 1 0

0

Group 2

11.88±2.61 9.16±2.09****
Group 3 22.13±3.09

17.78±5.55****

RESTING METABOLISM

1753.28±337.49 1580.44±385.33* NA
Group 1 0

0

Group 2

1443±167.99 1355±141.51 NS
Group 3 1846.36±320.35

1648.08±410.52 NS

SUBCUTANEOUS FAT

33.61±7.12 30.35±7.21**** 9.69%↓
Group 1 0

0

Group 2

30.36±7.13 27.38±7.61****
Group 3 34.53±6.92

31.20±7.00****

SKELETAL MUSCLE MASS

23.47±3.12 24.67±3.54**** 5.11%↑
Group 1 0

0

Group 2

23.87±3.58 24.85±4.20**
Group 3 23.35±3.02

24.62±3.39***

WAIST CIRCUMFERENCE

110.97±15.26 98.40±11.96**** 11.32%↓
Group 1 0

0

Group 2

95.55±4.74 86.38±4.71****
Group 3 115.75±14.19

102.13±11.04****

Data are represented as mean ± SD ****p<0.0001 ***p<0.001 **p<0.01 ns = non-significant

Group 1: Normal BMI, Group 2: Overweight, Group 3: Obesity

Table 4 shows that only 39 subjects could sustain the routine by 4th month, and all normal BMI patients left the study due to achieving their goals. Groups 2 and 3 had 9 and 30 individuals respectively. All parameters and sub-divisions significantly decreased except resting metabolism. BMI and body weight had reduced by 10.01% and 9.81%. Body fat, visceral fat, subcutaneous fat, and waist circumference reduced by 7.52%, 20.09%, 9.69%, and 11.32% respectively. Skeletal muscle mass improved by 5.11%, which was a significant increase.

Table 5: Shows Anthropometric data before and after 5 months of Intermittent Fasting

Parameters

Before IF After 5th month(n=19)

Percent Change

BMI

32.11±4.21 28.26±3.17**** 11.99%↓
Group 1 0

0

Group 2

27.84±1.48 25.48±1.19****
Group 3 34.6±3.09

29.88±2.82****

BODY WEIGHT

73.44±24.83 64.98±21.99**** 11.51%↓
Group 1 0

0

Group 2

71.5±6.18 65.45±5.21***
Group 3 74.58±31.37

64.70±27.86****

BODY FAT

38.54±5.66 34.92±6.27**** 9.39%↓
Group 1 0

0

Group 2

35.57±6.40 32.87±6.67**
Group 3 3.72±4.60

5.00±5.99****

VISCERAL FAT

18.02±5.89 13.21±5.25**** 26.69%↓
Group 1 0

0

Group 2

12.28±2.64 9.35±2.13**
Group 3 21.37±4.45

15.45±5.26****

RESTING METABOLISM

1655±271.16 1519.68±235.49 NS NA
Group 1 0

0

Group 2

1460.57±185.20 1381.14±170.23 NS
Group 3 1768.83±251.83

1600.5±235.79 NS

SUBCUTANEOUS FAT

33.37±8.04 29.63±7.89**** 11.20%↓
Group 1 0

0

Group 2

29.75±7.64 27±7.40***
Group 3 35.49±7.79

31.16±8.07****

SKELETAL MUSCLE MASS

23.36±3.60 24.47±4.09** 4.75%↑
Group 1 0

0

Group 2

24.11±4.04 25.05±4.18**
Group 3 22.92±3.42

24.14±4.18*

WAIST CIRCUMFERENCE

107.36±11.73 92.84±8.38**** 13.52%↓
Group 1 0

0

Group 2

96.28±5.08 86.85±2.41***
Group 3 113.83±9.35

96.33±8.71****

Data are represented as mean ± SD ****p<0.0001 ***p<0.001 **p<0.01 ns = non-significant

Group 1: Normal BMI, Group 2: Overweight, Group 3: Obesity

Only 19 subjects completed the 5-month study; the table 5 shows data of 7and 12 subjects in groups 2 and 3 respectively. TheBMI, weight, body fat, visceral fat, subcutaneous fat, and waist circumference reduction percentage was 11.99%, 11.51%, 9.39%, 26.69%, 11.20%, and 13.52%,respectively.Resting metabolism showed non-significant reduction and skeletal muscle mass significantly increased by 4.75%.

Table 6: Shows Anthropometric data before and after 6 months of Intermittent Fasting

Parameters

Before IF After 6th month(n=8)

Percent Change

BMI

32.32±5.69 28.08±4.20** 13.11%↓
Group 1 0

0

Group 2

28.05±2.05 24.85±1.30**
Group 3 36.6±4.76

31.32±3.39*

BODY WEIGHT

85.26±17.95 74.02±14.33** 13.18%↓
Group 1 0

0

Group 2

69.17±3.87 61.4±3.13**
Group 3 101.35±6.86

86.65±6.66*

BODY FAT

39.31±4.19 36.15±5.26** 8.03%↓
Group 1 0

0

Group 2

38.83± 2.93 36.4±2.09*
Group 3 42±3.34

38.16±7.05 NS

VISCERAL FAT

17.18±7.63 12.81±6.68**** 25.43%↓
Group 1 0

0

Group 2

11.25±2.36 8.00±1.41*
Group 3 23.12±6.03

17.62±6.36**

RESTING METABOLISM

1639.25±329.90 1488.75±265.72 NS NA
Group 1 0

0

Group 2

1363.25±63.79 1261.50±43.37 NS
Group 3 1915.25±216.22

1716±158.61NS

 SUBCUTANEOUS FAT

33.88±6.90 30.07±7.46**** 11.142%↓
Group 1 0

0

Group 2

33.76±2.85 30.33±2.12*
Group 3 33.97±9.48

29.87±10.41*

SKELETAL MUSCLE MASS

22.61±2.97 23.85±3.42*** 5.48%↑
Group 1 0

0

Group 2

21.6±1.61 22.6±0.81 NS
Group 3 23.62±3.921

25.1±4.74 NS

WAIST CIRCUMFERENCE

107±13.52 92.25±8.44*** 11.24%↓
Group 1 0

0

Group 2

96.5±5.19 85±2.44*
Group 3 117.5±10.27

99.5±4.50*

Data are represented as mean ± SD ****p<0.0001 ***p<0.001 **p<0.01 ns = non-significant

Group 1: Normal BMI, Group 2: Overweight, Group 3: Obesity

Table 6 shows that only eight participants continued the 6-month study, and groups 2 and 3 both had four individuals. The BMI, weight, body fat, visceral fat, subcutaneous fat, and waist circumference reduction percentage was 13.11%, 13.18%, 8.03%, 25.43%, 11.24%, and 13.78% respectively. Body fat in group 3 individualsshowed non-significant reduction;and skeletal muscle mass in both groups was non-significantly increased, but overall skeletal muscle mass significantly increased by 5.48%. Resting metabolism showed non-significant reduction (9.18%).

The magnitude of the observed difference was quantifiedand the mean effect size was 2.29 across all comparisons.

Discussion

All creatures on Earth have evolved circadian oscillators that permit them to anticipate and get ready for activity, food consumption, and sleep at particular times due to the 24-hour cyclicity in environmental conditions and the daily rhythm of food convenience and predator evasion. Cycles of feeding and fasting changes the metabolic state and have a circadian rhythm of molecular responses over a 24 hour period. Thus, the circadian oscillator and time-of-feeding coordinate daily patterns ofgene expression and protein activity, allowing the body toanticipate and respond to feeding actions properly each day.7The interruption of circadian rhythms, whether through genetic manipulation in animals or behavioural changes in shift workers, has been shown to disturb such temporal regulationand can lead to an increased risk of metabolic syndromes.8 Frequent caloric intake in diet-induced obese animal models disrupt molecular circadian rhythms, which can harm metabolic regulation and increase the risk of obesity-related health issues.9

Over the past few years, an eating habit consisting of three main meals and multiple snacks in between has become a norm in our society and it can be challenging to adopt a fasting protocol in our daily lives. In this study, 239participants were recruited in the initial month, but some of them couldnot adopt and continue this regimenand we observed a decline in participant numbers during the studyperiod. In prior research some participants reported excessive hunger pangs, being short-tempered, and having trouble focusing during the initial period offasting regimen. However, these adverse effects are known to go away in about a month. We noticed that after the initial excitement, the third to fifth days were most challenging in majority individuals of our study, and if they could sustain till a week, they were more likely to continue successfully. In the initial first few days, we advised individuals to not be tough on themselves, listen to their bodies and give the system time to adapt to the new regimen.Hence, we met the individuals every fifteen days to collect data and did telephonic follow up every week as and when required to keep the motivation high and we were available for any queries they might have. Therefore, it is critical to raise awareness of these concerns and maintain motivation among those starting IF during this time.10

The present data demonstrates a significant increase in the percentage of BMI decrease (from 4.12% to 13.11%) directly proportional to months of fasting (1 to 6). Weight and body fat were significantly reduced after TRE. Our study validates that weight loss by fasting protocol is dependent on BMI, and chances are that higher the BMI more would be the weight loss and vice-versa. After 2 months of TRE, individuals with normal BMI exhibited a non-significant decrease in BMI and body fat, which is interpreted as a positive effect ofTRE. This is an important observation for individuals with normal BMI who want to pursue fasting for medical benefits but are not interested in weight loss.

Visceral adipose tissue acts as both a paracrine and endocrine organ by producing adipokines. Some of these adipokines, like leptin, are pro-inflammatory and cause chronic low-level inflammation, while others, like adiponectin, have anti-inflammatory properties. 11 Leptin is recognized for its pivotal role in controlling of the body weight through the signalling mechanism directed towards the hypothalamus and other associated brain regions. This signalling pathway serves to reduce food intake and concurrently elevate energy expenditure.12 In obese conditions, elevated levels of BMI cause insulin resistance and the development of leptin resistance. High accumulation of visceral fat dropsthe level of adiponectin. A normal to high level of adiponectin is associated with the oxidation of fatty acids, an increase in skeletal muscle mass, a decrease in hepatic gluconeogenesis, and an increase in glucose uptake. The body switches during fasting from using glucose as its primary fuel source to fatty acids and ketones. The body starts to move during this phase, from producing and storing lipids to activating fat through free fatty acids and ketone bodies. Some of the advantageous outcomes of intermittent fasting have been linked to this metabolic reprogramming, or shift in energy source.13 Our study demonstrated a substantial reduction in visceral fat and waist circumference and a clear increase in skeletal muscle mass. Hence, thisfasting regimenhas decreased adiposity, especially truncal and visceral fat.

Our studysystematically examined the relationship between eating patterns, healthy food consumption, and metabolic health. Obesity exerts substantial health effects, encompassing cardiovascular disease, high blood pressure, type II diabetes mellitus, hyperlipidaemia, osteoarthritis, obstructive sleep apnea, and certain cancers. It is also a recognized independent risk factor for numerous non-communicable diseases. The escalating health-related costs associated with treating these diseases, coupled with a decline in overall public efficiency, can inflict immediate and severe harm on the community in terms of health and financial losses.13 Therefore, reducing abdominal obesity unequivocally reduces the risk of all metabolic syndromes. Multiple studies have consistently shown decreased waist circumference and improved body composition with Time-Restricted Eating.14,15 Our research showed similar results in reducing abdominal obesity and subcutaneous fat, indicating a decrease in the risk of non-alcoholic fatty liver. TRE can be deemed an effective dietary strategy for weight management and improved metabolic well-being in individuals capable of successfully adhering to a restricted feeding window.

In our study, participants demonstrated a non-significant reduction or stable resting metabolic rate throughout the study period. This work comprehensively adds to the evidence that links TRE with weight loss by providing data from a clinic setting. Furthermore, it presents a well-structured framework for future research on this topic. Similarly, a previous study also lends support to our observations that time-restricted eating is a viable strategy for improving body composition even without calorie restriction.15 In another study, participants lost a significant amount of weight after 3 monthsof fasting, consuming an average of 1388 kcal.10

Humans are diurnal and traditionally, have been eatingbetween the sunrise and sunset period, since they could forage for food during day time only. Hence, it is advisable to keep the eating window during daytime for optimal outcome.  One advantage is that according to individual’s schedule, this can be personalised and the period can change to a little less or more. Our body undergoes three cycles: ingestion, digestion, and elimination. By practicing TRE, we align ourselves with nature’s inherent eating pattern, allowing our bodies to rest and heal in between periods of digestion andnext ingestion. Fasting helps to recover because the body does not have to continuously spend energy on digestion, so it spends energy on healing. Some IF-based research has demonstrated a decrease in oxidative stress and life span extension in conjunction with a reduction of abdominal fat tissue.4

Limitation of the study is that individuals should be highly motivated to continue with this regimen and one can encounter high dropout rates. Once the desired results are obtained they might not continue with the regimen religiously but might do it infrequently. Hence, the observed findings cannot be reliably generalized to broader demographic groups.The weight loss observed could partly also be due to calorie restriction and proper diet during time restricted eating.

Conclusion

Our study provides some support to the existing literature that TRE is an effective option for patients with overweight and obesity management. The results suggest a positive association between TREprotocol and weight loss in a specific population of obese individualsand has a potential for reducing broader health risksand metabolic improvements, but further research is needed to confirm these findings. The skeletal muscle mass was preserved, indicating that the decrease in BMI was due to favourable changes in body composition. Additionally, the participants demonstrated a stable resting metabolic rate throughout the study period. These observations are consistent with the hypothesis that TRE may be a safe and effective intervention for overweight and obesity management for individuals who are motivated and willing to make lifestyle changes.Moreover, it has the advantage of being flexible, affordable and accessible worldwide.

Acknowledgement

The authors would like to specially thank all the individuals who participated in this study.

Funding Sources

PriyaChaudhary received the SHODH – ScHeme of Developing High Quality Research fellowship, by the Education Department of Gujarat, India. (Student Ref No: 2021013878)

Conflict of Interest

The authors do not have any conflict of interest.

Data Availability Statement

This statement does not apply to this article.

Ethics Statement

This study has received ethical clearance from the Institutional Ethics Committee of Gujarat University (Ref: GU-IEC(Niv)/02/PhD/033)

Informed Consent Statement

Informed consent was obtained from the participants and the privacy rights of human subjects was observed.

Clinical Trial Registration

This research does not involve any clinical trials.

Permission to Reproduce Material from Other Sources

Not Applicable

Author Contributions

  • Priya Chaudhary:Data Collection and Compilation, Results Analysis, Manuscript Drafting.
  • Rajesh Hydrabadi:Conceptualization, Consultant Doctor,Started “The Intermittent Fasting Research Foundation”(IFRF), Ahmedabad, India.
  • Sumit Prajapati:Supervision, Consultant Doctor.
  • Divya Chandel:Study Design, Result Interpretation,Supervision, Manuscript Preparation.

References

  1. Madkour MI, Malhab LJ, Abdel-Rahman WM, et al. Ramadan diurnal intermittent fasting is associated with attenuated FTO gene expression in subjects with overweight and obesity: a prospective cohort study. Frontiers in Nutrition. 2022 Mar 17;8:741811.
    CrossRef
  2. Obesity and overweight. 2016. Accessed February 26, 2024. https://www.who.int/news-room/fact-sheets/detail/obesity-and-overweight
  3. Nowosad K, Sujka M. Effect of various types of intermittent fasting (IF) on weight loss and improvement of diabetic parameters in human. Current nutrition reports. 2021 Jun;10(2):146-54.
    CrossRef
  4. Antoni R, Johnston KL, Collins AL, et al. Investigation into the acute effects of total and partial energy restriction on postprandial metabolism among overweight/obese participants. British Journal of Nutrition. 2016 Mar;115(6):951-9.
    CrossRef
  5. Ku M, Fung J, Ramos M. Therapeutic fasting as a potential effective treatment for type 2 diabetes: A 4-month case study. Journal of Insulin Resistance. 2017 May 24;2(1):1-5.
    CrossRef
  6. Zubrzycki A, Cierpka-Kmiec K, Kmiec Z, et al. The role of low-calorie diets and intermittent fasting in the treatment of obesity and type-2 diabetes. Journal of Physiology & Pharmacology. 2018 Oct 1;69(5).
  7. Adamovich Y, Rousso-Noori L, Zwighaft Z, et al. Circadian clocks and feeding time regulate the oscillations and levels of hepatic triglycerides. Cell metabolism. 2014 Feb 4;19(2):319-30.
    CrossRef
  8. Asher G, Schibler U. Crosstalk between components of circadian and metabolic cycles in mammals. Cell metabolism. 2011 Feb 2;13(2):125-37.
    CrossRef
  9. Kohsaka A, Laposky AD, Ramsey KM, et al. High-fat diet disrupts behavioral and molecular circadian rhythms in mice. Cell metabolism. 2007 Nov 7;6(5):414-21.
    CrossRef
  10. Salis S, Shefa S, Sharma N, Vora N, et al. Effects of intermittent fasting on weight loss in asian indian adults with obesity. J Assoc Physicians India. 2022 Sep 1;70(9):11-2.
    CrossRef
  11. López-Jaramillo P, Gómez-Arbeláez D, López-López J, et al. The role of leptin/adiponectin ratio in metabolic syndrome and diabetes. Hormone molecular biology and clinical investigation. 2014 Apr 1;18(1):37-45.
    CrossRef
  12. Minokoshi Y, Toda C, Okamoto S. Regulatory role of leptin in glucose and lipid metabolism in skeletal muscle. Indian journal of endocrinology and metabolism. 2012 Dec 1;16(Suppl 3):S562-8.
    CrossRef
  13. Albosta M, Bakke J. Intermittent fasting: is there a role in the treatment of diabetes? A review of the literature and guide for primary care physicians. Clinical diabetes and endocrinology. 2021 Feb 3;7(1):3.
    CrossRef
  14. Phillips NE, Mareschal J, Schwab N, et al. The effects of time-restricted eating versus standard dietary advice on weight, metabolic health and the consumption of processed food: a pragmatic randomised controlled trial in community-based adults. Nutrients. 2021 Mar 23;13(3):1042.
    CrossRef
  15. Sampieri A, Paoli A, Spinello G et al. Impact of daily fasting duration on body composition and cardiometabolic risk factors during a time-restricted eating protocol: a randomized controlled trial. Journal of Translational Medicine. 2024 Dec;22(1):1-3.
    CrossRef
Visited 1 times, 1 visit(s) today
Citations

Article Publishing History
Received on: 18 Sep 2025
Accepted on: 01 Dec 2025

Article Review Details
Reviewed by: Amany Salama
Second Review by: Nikita Mishra
Final Approval by: Dr. Suhad Bahijri


Share

Visited 1 times, 1 visit(s) today